Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positron Emission Tomography”

2,484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,484 results

Very early researchStudy completedNCT05280782
What this trial is testing

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group

Who this might be right for
Coronary Artery Disease
Washington University School of Medicine 8
Early research (Phase 1)Study completedNCT02187627
What this trial is testing

Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants

Who this might be right for
Alzheimer's Disease, Healthy Volunteer
Hoffmann-La Roche 52
Not applicableUnknownNCT05803746
What this trial is testing

PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Who this might be right for
Lung CancerColorectal Cancer
Peking University Cancer Hospital & Institute 20
Not applicableUnknownNCT01089270
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Very early researchWithdrawnNCT04795856
What this trial is testing

Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

Who this might be right for
Mitral Valve Regurgitation
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT01111851
What this trial is testing

Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 16
Not applicableUnknownNCT05242666
What this trial is testing

Quantiative MRI and Myelin-PET for the Assessment of Degenerative Cervical Myelopathy

Who this might be right for
Cervical Spondylosis With MyelopathyDegenerative Cervical Myelopathy
Cambridge University Hospitals NHS Foundation Trust 100
Not applicableUnknownNCT03310502
What this trial is testing

Variation of Genes Controlling Carbohydrate and Lipid Metabolism

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesObesity+3 more
Turku University Hospital 2,050
Testing effectiveness (Phase 2)Study completedNCT00227539
What this trial is testing

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 25
Early research (Phase 1)WithdrawnNCT02193672
What this trial is testing

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01209039
What this trial is testing

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Who this might be right for
Schizophrenia
GlaxoSmithKline 41
Early research (Phase 1)Study completedNCT01116804
What this trial is testing

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

Who this might be right for
Primary Liver Cancer
University Hospital, Ghent 36
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Not applicableStudy completedNCT01721473
What this trial is testing

Brain Nicotine Receptor Density in Veteran Smokers

Who this might be right for
Positron Emission Tomography
VA Office of Research and Development 184
Post-approval studies (Phase 4)Study completedNCT01664741
What this trial is testing

Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging

Who this might be right for
Nicotine Dependence
Johns Hopkins University 127
Not applicableLooking for participantsNCT06716294
What this trial is testing

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

Who this might be right for
Bone Cancer MetastaticRadiofrequency AblationSpine Metastases+1 more
National and Kapodistrian University of Athens 16
Early research (Phase 1)Study completedNCT05331729
What this trial is testing

Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Centre Hospitalier Universitaire Dijon 20
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Testing effectiveness (Phase 2)Study completedNCT00165568
What this trial is testing

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 20
Next Page